Workflow
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
GlobeNewswire· 2025-02-27 21:00
ROCKAWAY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Sparrow Ascent™ by Spark Biomedical, an FDA cleared non-invasive transcutaneous auricular neuromodulation device available by prescription for the treatment of opioid withdrawal symptoms, will be distributed by electroCore, Inc. within certain Department of Veterans Affairs (VA) facilities. “At Spark Biomedical, we are dedicated to pioneerin ...
authID to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
GlobeNewswire· 2025-02-27 21:00
DENVER, Feb. 27, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID”), a leading provider of biometric identity verification and authentication solutions, today announced the Company will report financial results for the fourth quarter and full year ended December 31, 2024 on Thursday, March 13, 2025 after the market close. Following issuance of the earnings release, authID Chief Executive Officer, Rhon Daguro and Chief Financial Officer, Ed Sellitto will host a webcast at 5:00 p.m. EDT to discuss the ...
HELLO MY NAME IS… ORBI
Prnewswire· 2025-02-27 21:00
SPHERE REVEALS ICONIC EMOJI CHARACTER'S NAME AND LAUNCHES NEW E-COMMERCE WEBSITE FEATURING ORIGINAL MERCHANDISE INCLUDING THE "ORBI COLLECTION" LAS VEGAS, Feb. 27, 2025 /PRNewswire/ -- Sphere Entertainment Co. (NYSE: SPHR) today formally introduced Orbi™ – the iconic emoji character that has appeared on the Exosphere and charmed fans around the world since its first appearance in 2023. Coinciding with this reveal, Sphere launched its brand-new e-commerce website featuring original Sphere merchandise, includ ...
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group
GlobeNewswire· 2025-02-27 21:00
NEWPORT BEACH, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC,” “our,” or “we”) (Nasdaq: ELAB), a diversified holding company, is proud to announce its annual sponsorship of TCA Venture Group’s (“TCA”) Orange County network for 2025. As a Southern California Network Sponsor, PMGC is actively pursuing investments and M&A opportunities to strengthen its portfolio while fostering local business growth and expanding its market presence. TCA Venture Group (formerly known as ...
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025
GlobeNewswire· 2025-02-27 21:00
CLEARWATER, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the fourth quarter and fiscal year 2024 will be released before the market opens on Thursday, March 13th. Management will host a conference call at 8:30 a.m. Eastern Time on Thursday, March 13th to discuss the results of the fourth q ...
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer
GlobeNewswire· 2025-02-27 21:00
- Trial to begin enrolling in April; expected primary completion in mid-2027 - - Primary study endpoint of rate of major pathological response - SAN DIEGO and SUZHOU, China, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced an investigator initiated (IIT) Phase 2 neoadjuvant trial of ADG126 for patients with stage II or stage III colorectal cancer. The new study (NCT06846268), led ...
CoreCivic Announces Four New Contract Modifications to Add Capacity for U.S. Immigration and Customs Enforcement
GlobeNewswire· 2025-02-27 21:00
BRENTWOOD, Tenn., Feb. 27, 2025 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it has entered into contract modifications to add capacity for up to a total of 784 detainees from U.S. Immigration and Customs Enforcement ("ICE") at its 2,016-bed Northeast Ohio Correctional Center, its 1072-bed Nevada Southern Detention Center, and its 1,600-bed Cimarron Correctional Facility in Oklahoma. In addition, CoreCivic has obtained a contract modification to specify that ICE may use ...
PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Newsfilter· 2025-02-27 21:00
PRINCETON, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced it has entered into securities purchase agreements with new and existing healthcare focused institutional investors as well as participation from certain directors of the Company, for the purchase and sale of 7,330,121 shares of its common stock (or common st ...
Coda Octopus Group Sets Fiscal First Quarter 2025 Earnings Conference Call for Monday, March 17, 2025, at 10 a.m. Eastern Time
GlobeNewswire· 2025-02-27 21:00
Orlando, FL, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (NASDAQ: CODA), a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology for real-time subsea intelligence and new generation augmented reality diving technology, will host a conference call on Monday, March 17, 2025 at 10:00 a.m. Eastern time to discuss its results for its fiscal first quarter ended January 31, 2025 (“FQ2025”). A press release detailing these results will be issued before t ...
Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues
Newsfilter· 2025-02-27 21:00
– Patent provides coverage into 2040 for key aspects of the bioreactor manufacturing system – – Symvess, the acellular tissue engineered vessel, is manufactured in this patented system – DURHAM, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the issuance of a U.S. Patent covering key aspects of the manufacturing of Symvess (acellular ti ...